DNAVSGLMD• 3 Months (Normalized)
DNA vs GLMD (Ginkgo Bioworks Holdings Inc. vs Galmed Pharmaceuticals Ltd.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+5.55%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GLMD Performance $3.62
+%
Galmed Pharmaceuticals Ltd.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+5.55 pts
DNA outperforming by 5.55 percentage points
DNAGLMD
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GLMD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | DNA Price | DNA Gain (%) | GLMD Price | GLMD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +5.55% | $- | - | |
| Sep 25, 2026 | $10.66 | +7.57% | $- | - | |
| Sep 24, 2026 | $10.25 | +3.43% | $- | - | |
| Sep 23, 2026 | $8.58 | -13.42% | $3.62 | +550.73% | -564.15% |
| Sep 22, 2026 | $9.37 | -5.45% | $- | - | |
| Sep 21, 2026 | $7.98 | -19.48% | $3.50 | +529.16% | -548.64% |
| Sep 18, 2026 | $7.88 | -20.48% | $3.40 | +511.18% | -531.66% |
| Sep 17, 2026 | $7.84 | -20.89% | $3.48 | +525.56% | -546.45% |
| Sep 16, 2026 | $7.06 | -28.76% | $3.41 | +512.98% | -541.74% |
| Sep 15, 2026 | $6.99 | -29.47% | $3.63 | +551.63% | -581.10% |
| Sep 14, 2026 | $7.01 | -29.26% | $3.82 | +586.68% | -615.94% |
| Sep 11, 2026 | $6.75 | -31.89% | $3.84 | +590.28% | -622.17% |
| Sep 10, 2026 | $6.78 | -31.58% | $4.03 | +624.43% | -656.01% |
| Sep 09, 2026 | $6.79 | -31.48% | $4.63 | +732.28% | -763.76% |
| Sep 08, 2026 | $6.94 | -29.97% | $3.83 | +587.58% | -617.55% |
Page 1 of 5